DBV Technologies (DBVT) Free Cash Flow Growth (1y) (2021 - 2026)
DBV Technologies (DBVT) Free Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
60.84% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
88.70% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-15.72% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
66.37% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
DBV Technologies |
6.63 Bn |
6.41 Bn |
-3.90 Mn |
-151.27% |
| Date | Value |
|---|
| Mar 31, 2026 |
-151.27% |
| Dec 31, 2025 |
-193.11% |
| Sep 30, 2025 |
-42.44% |
| Jun 30, 2025 |
5.28% |
| Mar 31, 2025 |
45.32% |
| Dec 31, 2024 |
13.61% |
| Sep 30, 2024 |
-16.46% |
| Jun 30, 2024 |
-39.23% |
| Mar 31, 2024 |
-71.95% |
| Dec 31, 2023 |
41.26% |
| Sep 30, 2023 |
3.91% |
| Jun 30, 2023 |
-145.20% |
| Mar 31, 2023 |
-1,198.14% |
| Dec 31, 2022 |
-21.30% |
| Sep 30, 2022 |
10.97% |
| Jun 30, 2022 |
65.19% |
| Mar 31, 2022 |
95.56% |
| Dec 31, 2021 |
41.25% |
| Sep 30, 2021 |
45.69% |
| Jun 30, 2021 |
26.12% |
